Cargando…
Multiple sclerosis: integration of modeling with biology, clinical and imaging measures to provide better monitoring of disease progression and prediction of outcome
Multiple Sclerosis (MS) is a major cause of neurological disability in adults and has an annual cost of approximately $28 billion in the United States. MS is a very complex disorder as demyelination can happen in a variety of locations throughout the brain; therefore, this disease is never the same...
Autor principal: | Goodwin, Shikha Jain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270418/ https://www.ncbi.nlm.nih.gov/pubmed/28197176 http://dx.doi.org/10.4103/1673-5374.195274 |
Ejemplares similares
-
Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis
por: Heidker, Rebecca M., et al.
Publicado: (2017) -
Better provision and marshalling of data needed to provide evidence of immunocontraception
por: Cooper, Trevor G
Publicado: (2014) -
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
por: Motl, Robert W, et al.
Publicado: (2017) -
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
por: Feys, Peter, et al.
Publicado: (2017) -
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2017)